Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
暂无分享,去创建一个
David J. Brooks | Roger A. Barker | James B. Rowe | Adrian M. Owen | David J. Burn | Michael J. Firbank | Adam Hampshire | Alison J. Yarnall | Tien K. Khoo | Trevor W. Robbins | John T. O’Brien | Patrick F. Chinnery | T. Robbins | R. Barker | A. Owen | J. O'Brien | J. Rowe | D. Brooks | D. Burn | A. Hampshire | M. Firbank | P. Chinnery | S. Winder-Rhodes | A. Yarnall | D. Breen | C. Nombela | T. Khoo | G. Duncan | Cristina Nombela | Gordon W. Duncan | David P. Breen | Sophie E. Winder-Rhodes
[1] John L. Robinson,et al. Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.
[2] A. Owen,et al. Hypoconnectivity and Hyperfrontality in Retired American Football Players , 2013, Scientific Reports.
[3] T. Robbins,et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. , 1988, Brain : a journal of neurology.
[4] Oury Monchi,et al. Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease , 2014, Neurobiology of Aging.
[5] M. Ban,et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. , 2007, Annals of neurology.
[6] B. Schmand,et al. Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.
[7] M. D’Esposito,et al. Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.
[8] P. Moberg,et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. , 2011, Archives of neurology.
[9] M. Ban,et al. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. , 2013, Brain : a journal of neurology.
[10] T. Robbins,et al. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.
[11] S. Tsuji,et al. Apolipoprotein E ε4 allele and progression of cortical Lewy body pathology in Parkinson’s disease , 1998, Acta Neuropathologica.
[12] J. Poirier,et al. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain , 2012, Experimental Neurology.
[13] T. Robbins,et al. Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease , 2007, The Journal of Neuroscience.
[14] P. Goldman-Rakic,et al. Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] Keith A. Johnson,et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia , 2013, Neurology.
[16] K. Hugdahl,et al. Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia , 2006, Movement disorders : official journal of the Movement Disorder Society.
[17] J. Haines,et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.
[18] J. Jolles,et al. Functional integration of parietal lobe activity in early Alzheimer disease , 2012, Neurology.
[19] Xuemei Huang,et al. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. , 2006, Archives of neurology.
[20] D. Aarsland,et al. The Epidemiology of Dementia Associated with Parkinson's Disease , 2010, Brain pathology.
[21] T. Robbins,et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.
[22] T. Robbins,et al. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. , 2012, Brain : a journal of neurology.
[23] G. Halliday,et al. The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.
[24] D. Aarsland,et al. The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.
[25] A. Siderowf,et al. Genetic influences on cognitive decline in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[26] Mark S. Cohen,et al. Changes in cortical activity during mental rotation. A mapping study using functional MRI. , 1996, Brain : a journal of neurology.
[27] Susan Bookheimer,et al. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. , 2009, Annual review of clinical psychology.
[28] T. Shallice. Specific impairments of planning. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[29] Adrian M. Owen,et al. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man , 1995, Neuropsychologia.
[30] Keith A. Johnson,et al. Brain amyloid and cognition in Lewy body diseases , 2012, Movement disorders : official journal of the Movement Disorder Society.
[31] I. M. Harris,et al. Selective right parietal lobe activation during mental rotation: a parametric PET study. , 2000, Brain : a journal of neurology.
[32] W. C. Culbertson,et al. Evidence for Impaired Encoding and Retrieval Memory Profiles in Parkinson Disease , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.
[33] A. Owen. Working memory in dorsolateral frontal cortex , 1998, Trends in Cognitive Sciences.
[34] P. Thompson,et al. Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[35] H. Nelson,et al. Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.
[36] Adam Hampshire,et al. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. , 2008, Brain : a journal of neurology.
[37] Juliet M. Taylor,et al. Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease , 2013, Neurochemistry International.
[38] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[39] A. Goris,et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease , 2009, Journal of Neurology.
[40] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[41] K. Fuxe,et al. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat , 1981, Neuroscience Letters.
[42] L. Forsgren,et al. Cognitive function in early Parkinson’s disease: a population‐based study , 2009, European journal of neurology.
[43] T. Goldberg,et al. Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.
[44] S. Tiamkao,et al. Association between apolipoprotein E genotypes and Parkinson’s disease , 2011, Journal of Clinical Neuroscience.
[45] E. Tolosa,et al. Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease , 2013, Hippocampus.
[46] A. Grunewald. Stimulating thoughts about heading perception , 1998, Trends in Cognitive Sciences.
[47] Adrian M. Owen,et al. Fractionating Human Intelligence , 2012, Neuron.
[48] E. Tolosa,et al. Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease , 2008, Neuroscience Letters.
[49] R. Camicioli,et al. Source memory in normal aging and Parkinson's disease. , 2013, Journal of neuropsychology.
[50] O. Tysnes,et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. , 2013, JAMA neurology.
[51] Jeffrey M. Zacks,et al. Neuroimaging Studies of Mental Rotation: A Meta-analysis and Review , 2008, Journal of Cognitive Neuroscience.
[52] A. Cronin-Golomb,et al. Visuospatial dysfunction and problem solving in Parkinson's disease. , 1997, Neuropsychology.
[53] P. Grasby,et al. The Effects of The COMT val108/158met Polymorphism on BOLD Activation During Working Memory, Planning, and Response Inhibition: A Role for The Posterior Cingulate Cortex? , 2011, Neuropsychopharmacology.
[54] I. Deary,et al. COMT genotype and cognitive ability: A longitudinal aging study , 2007, Neuroscience Letters.
[55] David N. Rider,et al. Genomic determinants of motor and cognitive outcomes in Parkinson's disease. , 2012, Parkinsonism & related disorders.
[56] H. Goodglass,et al. Some linguistic structures in the speech of a Broca's aphasic. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.
[57] Matthew Brett,et al. Dissociable contributions of the mid-ventrolateral frontal cortex and the medial temporal lobe system to human memory , 2006, NeuroImage.
[58] M. Onofrj,et al. Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks. , 2010, Parkinsonism & related disorders.
[59] Karl J. Friston,et al. Scanning patients with tasks they can perform , 1999, Human brain mapping.
[60] K. Heilman,et al. Mental object rotation in Parkinson's disease , 2003, Journal of the International Neuropsychological Society.
[61] Ivan Toni,et al. The prefrontal cortex: response selection or maintenance within working memory? , 2000, 5th IEEE EMBS International Summer School on Biomedical Imaging, 2002..
[62] Arthur L. Benton,et al. Differential behavioral effects in frontal lobe disease , 1968 .
[63] Angie A. Kehagia,et al. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.
[64] Yoav Ben-Shlomo,et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.
[65] Lars-Göran Nilsson,et al. Catechol O-Methyltransferase Val158Met Polymorphism is Associated with Cognitive Performance in Nondemented Adults , 2005, Journal of Cognitive Neuroscience.
[66] C. Marsden,et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.
[67] R. Dolan,et al. Neural systems engaged by planning: a PET study of the Tower of London task , 1996, Neuropsychologia.
[68] D. Aarsland,et al. Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. , 2011, Neuropsychology.
[69] R. Poldrack. Region of interest analysis for fMRI. , 2007, Social cognitive and affective neuroscience.
[70] T. Robbins,et al. Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry , 2003, The Journal of Neuroscience.
[71] Roger A. Barker,et al. Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis , 2012, Neurodegenerative Diseases.
[72] J. Nutt,et al. The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile , 2008, Movement disorders : official journal of the Movement Disorder Society.
[73] M. Egan,et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.
[74] B. Schmand,et al. Catechol‐O‐methyltransferase val158met and cognitive function in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[75] A. Lee,et al. Impairments of mental rotation in Parkinson's disease , 1998, Neuropsychologia.
[76] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[77] L. Nyberg,et al. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study , 2012, The Lancet Neurology.
[78] M. Petrides,et al. Functional organization of spatial and nonspatial working memory processing within the human lateral frontal cortex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. Nalls,et al. A large study reveals no association between APOE and Parkinson's disease , 2012, Neurobiology of Disease.
[80] M. Barcikowska,et al. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors , 2013, Neurobiology of Aging.
[81] D. Eckstein,et al. Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition , 2008, Brain : a journal of neurology.
[82] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[83] John Duncan,et al. Frontal lobe involvement in spatial span: Converging studies of normal and impaired function , 2006, Neuropsychologia.
[84] T. Robbins,et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism , 2004, Movement disorders : official journal of the Movement Disorder Society.
[85] T. Robbins,et al. Characterizing mild cognitive impairment in incident Parkinson disease , 2014, Neurology.
[86] A M Owen,et al. Prefrontal dopamine levels determine the balance between cognitive stability and flexibility. , 2013, Cerebral cortex.
[87] A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson’s disease , 2014, Acta Neurologica Belgica.
[88] Alan C. Evans,et al. Planning and Spatial Working Memory: a Positron Emission Tomography Study in Humans , 1996, The European journal of neuroscience.
[89] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[90] Thomas Foltynie,et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.
[91] S. Tsuji,et al. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. , 1998, Acta neuropathologica.
[92] K. Marder,et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study , 2010, Journal of the International Neuropsychological Society.
[93] Michael C. Corballis,et al. Mental Rotation and the Right Hemisphere , 1997, Brain and Language.
[94] T. Robbins,et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[95] T. Robbins,et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.
[96] J. Kulisevsky,et al. Cognitive impairment in nondemented Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[97] W. Gowers,et al. A Manual of Diseases of the Nervous System , 1887, Edinburgh Medical Journal.
[98] R. Barker,et al. The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease , 2010, Neurobiology of Aging.
[99] R. E. Passingham,et al. Imaging the mental components of a planning task , 2001, Neuropsychologia.
[100] G. Ganis,et al. Frontostriatal circuits are necessary for visuomotor transformation: Mental rotation in Parkinson's disease , 2006, Neuropsychologia.